The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products
Abstract Background: Use of cannabis-based products is becoming more frequent, and it is important that healthcare professionals are informed and…
Abstract Background: Use of cannabis-based products is becoming more frequent, and it is important that healthcare professionals are informed and…
Abstract Cannabidiol (CBD) has shown promise in treating psychiatric disorders, including cannabis use disorder – a major public health burden…
Abstract Rationale: Chronic cannabis use is associated with impaired cognitive function. Evidence indicates cannabidiol (CBD) might be beneficial for treating…
Abstract Background: Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the two major constituents of cannabis with contrasting mechanisms of action. THC…
Abstract Rationale: There is growing interest in the therapeutic potential of cannabidiol (CBD) across a range of psychiatric disorders. CBD…
Abstract Background: The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence…
Abstract The standardization of cannabis doses is a priority for research, policy-making, clinical and harm-reduction interventions and consumer security. Scientists…
Abstract Background: Public and medical interest in cannabidiol (CBD) has been rising, and CBD is now available from various sources.…
Abstract Cannabis has been legalised for medical use in an ever-increasing number of countries. A growing body of scientific evidence…
Abstract Background: Cannabidiol (CBD) is being investigated as a potential treatment for several medical indications, many of which are characterised…